Apigenin vs. Quercetin: How Two Common Flavonoids Differ in Mechanism and Potential Use

Apigenin and quercetin are among the most studied plant flavonoids, yet they belong to different flavonoid subclasses, appear in different foods, and interact with the body through partly distinct pathways. Understanding how they differ, and where they overlap, can help you make a more informed choice if you are considering either as a dietary supplement.

Both compounds are found naturally in fruits, vegetables, and herbs, and both have attracted scientific attention for antioxidant, anti-inflammatory, and potential anticancer properties. Neither is a medicine, and neither should be treated as one. What follows is an honest summary of what current research does and does not support.

Chemical Structure: Flavone vs. Flavonol

Apigenin (4′,5,7-trihydroxyflavone) is a flavone: a subclass defined by a double bond between carbons 2 and 3 and no hydroxyl group at the 3-position. Quercetin is a flavonol, which shares the same double bond but adds a hydroxyl group at C-3. That single structural difference has meaningful downstream effects on how each molecule behaves chemically and biologically.

Quercetin’s extra hydroxyl group gives it a greater number of electron-donation sites. Apigenin has fewer hydroxyl groups and bound the benzodiazepine site in rat brain assays (Ki 4 microM), but quercetin has also shown benzodiazepine-site-linked anxiolytic-like activity in mice, so the receptor does not cleanly separate them ^[12][13]. In flavonoid biology, structure is closely tied to function.

Antioxidant and Anti-inflammatory Activity

No verified head-to-head antioxidant ranking of quercetin against apigenin is available, so claims that either is stronger rest on assay chemistry rather than on human data. Its ability to quench reactive oxygen and nitrogen species has been examined across multiple cell models; different dietary flavonoids produce meaningfully different antioxidant enzyme responses in human liver cells challenged with proinflammatory cytokines, underscoring that flavonoids are not interchangeable despite sharing a core scaffold ^[4].

In cultured human umbilical vein endothelial cells activated with TNF-alpha, the flavones luteolin and apigenin at 25 micromol/L or more almost completely abolished the rise in adhesion molecules by blocking NF-kappa B ^[1]. This pathway is relevant to vascular inflammation, though findings in cell culture do not automatically translate to clinical benefit. A head-to-head comparison with quercetin on this pathway is not in the published research reviewed.

In cell studies the results are mixed: apigenin lowered COX-2 levels in LPS-activated mouse macrophages where quercetin raised them, but in human Chang liver cells apigenin at 25-50 microM increased peroxide and nitric oxide generation while quercetin prevented it ^[14][4]. Flavonoid glycosides more broadly have demonstrated antioxidant activity across botanical sources ^[5], reinforcing that both aglycone and glycoside forms contribute to overall dietary antioxidant load. Neither profile is inherently superior; the more relevant compound depends on which biological context is being considered.

Editor’s Pick

Double Wood Apigenin 50 mg, NSF Certified, 120 Capsules (Powerful Bioflavonoid Found in Chamomil

50mg120 count

Check Price on Amazon › As an Amazon Associate we earn from qualifying purchases.

Cancer Research: Shared Interest, Different Mechanisms

Both flavonoids have been studied extensively in preclinical cancer models. In human LNCaP and PC-3 prostate cancer cells apigenin caused cell cycle arrest in the G0-G1 phase, a cell-culture result and not a supplement dose ^[15]. Research examining apigenin’s role in skin inflammatory diseases and cancer suggests it modulates multiple intracellular targets, positioning it as a candidate for ongoing investigation ^[2].

Human data on dietary apigenin and cancer are null or borderline: in a large case-control study of ovarian cancer the highest versus lowest apigenin intake quintile gave RR 0.79 (95% CI 0.59-1.06), not significant, and pooled prospective-cohort risk for flavone intake in colorectal cancer was RR 1.02 (CI 0.94-1.11), no association ^[24][25].

Quercetin’s anticancer activity spans multiple signaling pathways including PI3K/Akt and MAPK. Both quercetin and apigenin appear together in plants examined for digestive cancer prevention: Portulaca oleracea (purslane), which contains both compounds, has been studied in models of gastrointestinal inflammatory cancer transformation ^[6]. Mediterranean dietary polyphenols, quercetin among them, have also been associated in observational data with reduced colorectal cancer risk, though establishing causation from dietary cohort studies remains methodologically difficult ^[7].

Flavonoid-modulated JAK-STAT signaling is another pathway under active investigation for its relevance to malignant transformation and drug resistance in breast tumors, with quercetin and related compounds demonstrating activity at this node ^[8]. Nano-encapsulation strategies are being explored for both compounds to improve bioavailability and targeted delivery, given that raw oral bioavailability of most polyphenols is limited ^[9][10]. All of this research is preclinical or early-stage; neither compound is an approved cancer treatment.

NAD+ and Metabolic Support: An Apigenin-Specific Angle

One area where apigenin has drawn particular recent attention is NAD+ metabolism. CD38, an enzyme that degrades NAD+, is one of the primary routes through which NAD+ levels decline with age. In a purified human CD38 enzyme assay apigenin inhibited CD38 NAD+ase activity with an IC50 of 10.3 micromol/L, a test-tube concentration, and daily injections raised liver NAD+ in obese mice. Whether dietary or supplemental apigenin does this in people has not been tested in the research reviewed ^[16].

In the same CD38 enzyme assay quercetin inhibited CD38 NAD+ase activity with an IC50 of 13.8 micromol/L, close to apigenin’s value ^[16]. Research on both compounds here remains early-stage, and human dosing data sufficient to guide supplementation are not yet well-established. Claims that either flavonoid reliably raises NAD+ levels in healthy adults to a clinically meaningful degree are not currently supported by robust clinical trial evidence.

Neurological and Sleep-Related Effects

Apigenin is unusual among common dietary flavonoids in its affinity for benzodiazepine-binding sites on GABA-A receptors. Chamomile has long been used as a calming herb, but its flowers hold mostly apigenin glycosides rather than free apigenin, and the human sleep and anxiety trials used whole chamomile extract, so they cannot show that apigenin is responsible. Receptor binding in rat brain assays is part of why apigenin has been studied for sleep onset and anxiety ^[17][18][12].

In mice, injected quercetin had an anxiolytic-like effect and strongly potentiated diazepam, and flumazenil reversed the effects, which suggests benzodiazepine-site GABA-A involvement. In frog oocytes, neither apigenin’s nor quercetin’s effect on GABA-A receptors was blocked by flumazenil, and apigenin on its own inhibited GABA activation. So the GABAergic mechanism does not clearly separate the two, and neither has human sleep data ^[13][19][20].

Premium Pick

aSquared Nutrition Apigenin 50mg & L-Theanine 200mg – 120 Capsules – Apigenin Supplement P

Capsules50mg120 count

Check Price on Amazon › As an Amazon Associate we earn from qualifying purchases.

Apigenin displaced a benzodiazepine-site ligand in rat brain binding assays, so combining it with benzodiazepine medications, alcohol or melatonin could in theory add to sedation; this has not been tested in people ^[12]. Individuals taking prescription sedatives or anxiolytics should consult a physician before adding apigenin.

Dietary Sources and Food Distribution

Apigenin is most concentrated in chamomile, parsley, and celery, where it exists partly as the glycoside apigenin-7-glucoside. It also appears in minor quantities in white tea; metabolomics profiling of white, green, and black teas has confirmed substantial variation in flavonoid compound profiles depending on processing method ^[11].

Quercetin is more widely distributed across the plant kingdom. Onions, particularly red onions, are among the richest sources, and significant amounts also appear in capers, apples, broccoli, and buckwheat. Because of this wider distribution, average dietary quercetin intake is typically higher than apigenin intake in populations consuming Western diets. Both compounds appear as glycosides in whole foods and are hydrolyzed to their aglycone forms during digestion, a conversion that affects absorption and bioavailability.

A Note on the Evidence

The evidence for both apigenin and quercetin is largely preclinical, drawn from cell culture and animal studies, and robust human clinical trials establishing effective doses, long-term safety, or confirmed health outcomes remain limited; in laboratory enzyme tests apigenin inhibited CYP1A2, CYP2C9 and CYP3A4 and it bound benzodiazepine sites in rat brain assays, so ^{[21][22][23][12]} individuals taking warfarin, certain statins, benzodiazepines, melatonin, or alcohol should consult a physician before supplementing, and these statements have not been evaluated by the FDA: neither compound is intended to diagnose, treat, cure, or prevent any disease.

Vitamatic Apigenin 50mg per Capsule, 120 Vegetarian Capsules, Chamomile-Derived Bioflavo

Capsules50mg

Check Price on Amazon › As an Amazon Associate we earn from qualifying purchases.

Frequently Asked Questions

Which is a stronger antioxidant, apigenin or quercetin?

Published research gives no clear human answer. In cultured human liver cells exposed to a cytokine mixture, apigenin at 25-50 microM increased peroxide and nitric oxide generation while quercetin prevented it, so quercetin looked more protective in that model ^[4]. Which compound is ‘stronger’ depends on the specific biological endpoint being measured.

Can apigenin and quercetin be taken together?

There is no well-established clinical evidence on combined supplementation. In laboratory enzyme tests apigenin inhibited CYP1A2, CYP2C9 and CYP3A4, so combining supplements could in theory raise drug-interaction risks for anyone on prescription medications; no clinical interaction study is in the published research reviewed ^[21][22][23]. Consult a physician before stacking either with pharmaceutical drugs, particularly warfarin, certain statins, or benzodiazepines.

Does apigenin help with sleep in a way quercetin does not?

No human trial shows that apigenin helps sleep more than quercetin does. Apigenin bound benzodiazepine sites in rat brain assays, but quercetin was also anxiolytic-like in mice through a benzodiazepine-site-linked effect. Chamomile has a long folk history as a calming herb, but its flowers hold mostly apigenin glycosides and the human trials used whole extract ^{[12][13][17][18]}. Caution is warranted when combining apigenin with other sedatives, including alcohol and prescription anxiolytics, due to the risk of additive sedation.

Are either of these flavonoids useful against cancer?

Both have shown activity against cancer cell lines and tumor models in preclinical studies through mechanisms including CDK inhibition (apigenin), JAK-STAT modulation ^[8], and NF-kB suppression ^[1]. Nano-formulations are being explored to improve delivery to tumor cells ^[9]. Neither is an approved cancer treatment, and preclinical results cannot be assumed to translate directly to humans.

What foods are the best sources of each?

Apigenin is most concentrated in chamomile, parsley, and celery; it also appears in white tea, where flavonoid profiles vary substantially by processing method ^[11]. Quercetin is more broadly distributed: onions, capers, apples, and buckwheat are particularly rich sources. For most people following a Western diet, quercetin intake from food is likely higher than apigenin intake.

Do apigenin and quercetin both support NAD+ levels?

Apigenin and quercetin both inhibited CD38 NAD+ase activity in a purified enzyme assay (IC50 10.3 and 13.8 micromol/L), but those are test-tube concentrations and no human NAD+ outcome for either is in the published research reviewed ^[16]. Both relationships remain at an early research stage. There is insufficient human clinical trial data to make firm dosing or efficacy claims for either compound in this context, and neither should be used as a replacement for established NAD+ precursors with stronger clinical backing.

References

1. Choi JS et al. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B. The Journal of nutrition (2004). PMID 15113938
2. Yoon JH et al. Apigenin: A Therapeutic Agent for Treatment of Skin Inflammatory Diseases and Cancer. International journal of molecular sciences (2023). PMID 36675015
3. Guo C et al. Therapeutic application of natural products: NAD(+) metabolism as potential target. Phytomedicine : international journal of phytotherapy and phytopharmacology (2023). PMID 36948143
4. Crespo I et al. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2008). PMID 18234413
5. Taiwo BJ et al. Antioxidant and antibacterial activities of flavonoid glycosides from Ficus exasperata Vahl-Holl (moraceae) leaves. African journal of traditional, complementary, and alternative medicines : AJTCAM (2014). PMID 25371569
6. Shao G et al. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug. Journal of ethnopharmacology (2024). PMID 38447616
7. Yammine A et al. Polyphenols of the Mediterranean Diet and Their Metabolites in the Prevention of Colorectal Cancer. Molecules (Basel, Switzerland) (2021). PMID 34201125
8. Kubatka P et al. Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation. Journal of advanced research (2026). PMID 41205803
9. Yıldırım M et al. Recent Strategies for Cancer Therapy: Polymer Nanoparticles Carrying Medicinally Important Phytochemicals and Their Cellular Targets. Pharmaceutics (2023). PMID 38004545
10. Khan H et al. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Seminars in cancer biology (2021). PMID 31374244
11. Dai W et al. Characterization of white tea metabolome: Comparison against green and black tea by a nontargeted metabolomics approach. Food research international (Ottawa, Ont.) (2017). PMID 28528106
12. Haydée Viola et al. Apigenin, a Component ofMatricaria recutitaFlowers, is a Central Benzodiazepine Receptors-Ligand with Anxiolytic Effects. Planta Medica (1995). PMID 7617761
13. Islam MS et al. Anxiolytic-like Effect of Quercetin Possibly through GABA Receptor Interaction Pathway: In Vivo and In Silico Studies. Molecules (Basel, Switzerland) (2022). PMID 36363979
14. López-Cánovas DJ et al. Buckwheat Flavonoids Modulate Inflammation in RAW 264.7 Macrophages at Physiologically Relevant Concentrations via the LPS/COX-2 Pathway. Journal of agricultural and food chemistry (2026). PMID 41824773
15. Shukla S et al. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell cycle (Georgetown, Tex.) (2007). PMID 17457054
16. Carlos Escande et al. Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38. Diabetes (2012). PMID 23172919
17. Corina Danciu et al. Botanical Therapeutics: Phytochemical Screening and Biological Assessment of Chamomile, Parsley and Celery Extracts against A375 Human Melanoma and Dendritic Cells. International Journal of Molecular Sciences (2018). PMID 30453564
18. Kramer DJ et al. Apigenin: a natural molecule at the intersection of sleep and aging. Frontiers in nutrition (2024). PMID 38476603
19. Goutman JD et al. Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors. European journal of pharmacology (2003). PMID 12586201
20. Campbell EL et al. The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors. Biochemical pharmacology (2004). PMID 15451406
21. Fei Lin et al. Inhibitory effect of Selaginella doederleinii hieron on human cytochrome P450. Frontiers in Pharmacology (2023). PMID 36874034
22. Shimada H et al. Differential mechanisms for the inhibition of human cytochrome P450 1A2 by apigenin and genistein. Journal of biochemical and molecular toxicology (2010). PMID 20806393
23. Kondža M et al. Characterization of the CYP3A4 Enzyme Inhibition Potential of Selected Flavonoids. Molecules (Basel, Switzerland) (2021). PMID 34069400
24. Gates MA et al. Flavonoid intake and ovarian cancer risk in a population-based case-control study. International journal of cancer (2009). PMID 19117058
25. Chang H et al. Dietary Flavonoids and the Risk of Colorectal Cancer: An Updated Meta-Analysis of Epidemiological Studies. Nutrients (2018). PMID 30041489
26. Maria-Corina Șerban et al. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association (2016). PMID 27405810

These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.